共 50 条
- [2] Efficacy of orlistat in overweight and obese patients with metabolic syndrome and its effects on the risk of coronary heart disease[J]. DIABETOLOGIA, 2004, 47 : A14 - A15Caterson, IGuy-Grand, BHill, J
- [3] Effect of orlistat on cardiovascular disease risk in obese adults[J]. DIABETES OBESITY & METABOLISM, 2005, 7 (03): : 254 - 262Swinburn, BACarey, DHills, APHooper, MMarks, SProietto, JStrauss, BJSullivan, DWelborn, TACaterson, ID
- [4] Effect of orlistat-assisted weight rose in decreasing coronary heart disease risk in patients with syndrome X[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (07): : 827 - 831Reaven, GSegal, KHauptman, JBoldrin, MLucas, C
- [5] Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension[J]. JOURNAL OF HYPERTENSION, 2002, 20 (09) : 1873 - 1878Sharma, AMGolay, A
- [6] Effect of weight management with orlistat on blood pressure in obese patients with hypertension[J]. OBESITY RESEARCH, 2001, 9 : 189S - 189SSharma, AMGolay, A
- [7] Treatment of hyperlipidaemia as a risk factor for coronary heart disease: the role of fibrates[J]. HOSPITAL MEDICINE, 1999, 60 (04): : 298 - 301Linssen, R
- [8] Effect of orlistat in overweight or obese patients with treated but inadequately controlled diastolic hypertension[J]. OBESITY RESEARCH, 2001, 9 : 188S - 188SBakris, GCalhoun, DEgan, BHellmann, CKingma, I
- [9] HYPERTENSION AS MODIFIABLE RISK FACTOR FOR CORONARY HEART DISEASE IN HEMODIALYZED PATIENTS[J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 484 - 484Korca, H.Gashi, M.Kocinaj, D.
- [10] Hyperlipidaemia and primary prevention of coronary heart disease: are the right patients being treated?[J]. JOURNAL OF CARDIOVASCULAR RISK, 2000, 7 (04): : 245 - 249Ramachandran, SLabib, MH